Nothing Special   »   [go: up one dir, main page]

DK543386D0 - Thienooxazinoner deres fremstilling og anvendelse - Google Patents

Thienooxazinoner deres fremstilling og anvendelse

Info

Publication number
DK543386D0
DK543386D0 DK543386A DK543386A DK543386D0 DK 543386 D0 DK543386 D0 DK 543386D0 DK 543386 A DK543386 A DK 543386A DK 543386 A DK543386 A DK 543386A DK 543386 D0 DK543386 D0 DK 543386D0
Authority
DK
Denmark
Prior art keywords
thienooxazinones
preparation
Prior art date
Application number
DK543386A
Other languages
English (en)
Other versions
DK543386A (da
Inventor
Werner Hallenbach
Hans Lindel
Friedrich Berschauer
Martin Scheer
Anno De Jong
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK543386D0 publication Critical patent/DK543386D0/da
Publication of DK543386A publication Critical patent/DK543386A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK543386A 1985-11-14 1986-11-13 Thienooxazinoner deres fremstilling og anvendelse DK543386A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853540377 DE3540377A1 (de) 1985-11-14 1985-11-14 Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer

Publications (2)

Publication Number Publication Date
DK543386D0 true DK543386D0 (da) 1986-11-13
DK543386A DK543386A (da) 1987-05-15

Family

ID=6285959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK543386A DK543386A (da) 1985-11-14 1986-11-13 Thienooxazinoner deres fremstilling og anvendelse

Country Status (7)

Country Link
US (1) US4760063A (da)
EP (1) EP0223140A2 (da)
JP (1) JPS62114989A (da)
DE (1) DE3540377A1 (da)
DK (1) DK543386A (da)
IL (1) IL80588A0 (da)
ZA (1) ZA868609B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693374A (en) 1994-06-23 1997-12-02 Fuji Photo Film Co., Ltd. Alpha-resorcyclic acid ester derivatives and recording materials using the same
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
ME00275B (me) * 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
ES2384160T3 (es) 1999-01-13 2012-07-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
HN2000000051A (es) * 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
PL368994A1 (en) * 2001-08-30 2005-04-04 Alizyme Therapeutics Limited Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
WO2003047579A1 (en) * 2001-12-03 2003-06-12 Bayer Pharmaceuticals Corporation Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
CN1620439A (zh) * 2001-12-20 2005-05-25 Osi药物公司 胰脂肪酶抑制剂化合物、其合成方法和应用
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
AU2003209119A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
EP1474393A1 (en) 2002-02-11 2004-11-10 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
JP4860474B2 (ja) 2003-05-20 2012-01-25 バイエル、ファーマシューテイカルズ、コーポレイション Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素
EP1663978B1 (en) 2003-07-23 2007-11-28 Bayer Pharmaceuticals Corporation Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
CN101010315A (zh) 2004-04-30 2007-08-01 拜耳制药公司 用于治疗癌症的取代的吡唑基脲衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2315303A1 (de) * 1973-03-27 1974-10-17 Bayer Ag Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen
US4036979A (en) * 1974-01-25 1977-07-19 American Cyanamid Company Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
US4234581A (en) * 1975-09-10 1980-11-18 Mead Johnson & Company Thieno[2,3-d]oxazines

Also Published As

Publication number Publication date
IL80588A0 (en) 1987-02-27
EP0223140A2 (de) 1987-05-27
ZA868609B (en) 1987-07-29
DK543386A (da) 1987-05-15
US4760063A (en) 1988-07-26
DE3540377A1 (de) 1987-05-21
JPS62114989A (ja) 1987-05-26

Similar Documents

Publication Publication Date Title
DK21986D0 (da) Tiazolidindionderivater og deres fremstilling og anvendelse
DK289886D0 (da) Substituerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK543386D0 (da) Thienooxazinoner deres fremstilling og anvendelse
DK129386D0 (da) Iodpropargylethere, deres fremstilling og anvendelse
DK546186D0 (da) Substituerede benzylethere, deres fremstilling og anvendelse
DK29686D0 (da) 13beta-alkyl-milbemycinderivater samt deres fremstilling og anvendelse
DK519586D0 (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK365286D0 (da) 7-oxabicycloheptan-substituerede disyre-diamid-prosta-glandin-analoge og deres anvendelse
DK515386A (da) Benzoylurinstofsalte samt deres fremstilling og anvendelse
DK380286D0 (da) Sulfonamider, deres fremstilling og anvendelse
DK396886D0 (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
DK617886A (da) 1-aryl-pyrazoler, deres fremstilling og anvendelse
DK172486A (da) Heterocyclyl-penem-forbindelser samt deres fremstilling og anvendelse
DK548586D0 (da) Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse
DK377786A (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
DK206686A (da) Acylaminomethyl-penem-forbindelser samt deres fremstilling og anvendelse
DK77286A (da) 1-0-acylerede hexosederivater samt deres fremstilling og anvendelse
DK393986A (da) Lactamamider, deres fremstilling og anvendelse
DK437986D0 (da) 1-amino-3-phenyl-propan-2-ol-derivater samt deres fremstilling og anvendelse
DK478586A (da) Polyhydroxyalkyl-oligourinstoffer og deres anvendelse
DK451486D0 (da) Alkenylazoler, deres fremstilling og anvendelse
DK195086D0 (da) Substituerede azolylmethylethere, deres fremstilling og anvendelse somfungicide midler
DK540786A (da) 2-hydroxybenzamider, deres fremstilling og anvendelse
DK471185D0 (da) 4-acylresorcinolethere samt deres fremstilling og anvendelse
DK482385D0 (da) Fluorerede resorcinolethere samt deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn
ATS Application withdrawn
ATS Application withdrawn